Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 13/20 | 0.53 |
| ▸ | ITGA2B | P08514 | 13/20 | 0.53 |
| ▸ | AOC3 | Q16853 | 4/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.43 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8542223 | 0.97 | ITGB3 (0.54) | ITGB3ITGA2BAOC3S1PR1S1PR3 | |
| SCHEMBL8547138 | 0.95 | ITGB3 (0.51) | ITGB3ITGA2BAOC3S1PR1S1PR3 | |
| SCHEMBL8550037 | 0.91 | ITGB3 (0.53) | ITGB3ITGA2BAOC3 | |
| SCHEMBL9425221 | 0.90 | ITGB3 (0.50) | ITGB3ITGA2BAOC3 | |
| SCHEMBL8547044 | 0.90 | ITGB3 (0.53) | ITGB3ITGA2BAOC3 | |
| SCHEMBL8548992 | 0.89 | ITGB3 (0.51) | ITGB3ITGA2BAOC3 | |
| SCHEMBL8543149 | 0.89 | ITGB3 (0.50) | ITGB3ITGA2BAOC3 | |
| SCHEMBL8545868 | 0.89 | ITGB3 (0.51) | ITGB3ITGA2BAOC3 | |
| SCHEMBL9425224 | 0.89 | ITGB3 (0.51) | ITGB3ITGA2BAOC3 | |
| SCHEMBL8545572 | 0.89 | ITGB3 (0.51) | ITGB3ITGA2BAOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0526402-B1 | Heteroaryl substituted hydroxylamine derivatives as lipoxygenase inhibitors | CIBA GEIGY AG (CH) | 1998-01-21 | — | — | EP | disclosed |
| US-5350761-A | Lipoxygenase inhibitors as antiinflammatory agents and antiallergens | CIBA-GEIGY CORPORATION (US) | 1994-09-27 | — | — | US | disclosed |
| US-5334600-A | Lipoxygenase inhibitors | CIBA-GEIGY CORPORATION (US) | 1994-08-02 | — | — | US | disclosed |
| US-5260316-A | Lipoxygenase inhibitor | CIBA-GEIGY CORPORATION (US) | 1993-11-09 | — | — | US | disclosed |
| EP-0526402-A1 | Heteroaryl substituted hydroxylamine derivatives as lipoxygenase inhibitors | CIBA-GEIGY AG (CH) | 1993-02-03 | — | — | EP | disclosed |